PVLA ▲ +0.2% - Palvella Therapeutics, Inc.
$PVLA - U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
28-SEP-2026 07:30 AM ET
Share this post
More filings for $PVLA
PVLA ▲ +0.5% - Palvella Therapeutics, Inc.Sep 9, 2026PVLA ▲ +0.0% - Palvella Therapeutics, Inc.Sep 2, 2026PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026PVLA - Palvella Therapeutics, Inc. - SEC Filing Update (10-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 10, 2026$PVLA SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 3, 2026
View full $PVLA filing history →💬 Comments
Loading comments…
Leave a comment